NextCure, Inc. (NXTC) Misses Q1 EPS by 17c
Tweet
Share
E-mailGet Alerts NXTC Hot Sheet
Join SI Premium – FREE
NextCure, Inc. (NASDAQ: NXTC) reported Q1 EPS of ($0.61), $0.17 worse than the analyst estimate of ($0.44).
For earnings history and earnings-related data on NextCure, Inc. (NXTC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Terra Innovatum Global N.V. (NKLR) Misses Q2 EPS by 12c
- Benchmark Reiterates Buy Rating on H World Group Ltd. (HTHT) Following Q2 Print
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
